Patent ID: 11952419
Assignee: UNIVERSITY OF CONNECTICUT
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. An isolated anti-human CD300c antibody, or fragment thereof, comprising each of the following complementarity determining regions (CDRs):
Heavy chain CDR1 (H-CDR1) comprising the amino acid sequence IYGMN (SEQ ID NO: 10);
Heavy chain CDR2 (H-CDR2) comprising the amino acid sequence WINTYT (SEQ ID NO: 11);
Heavy chain CDR3 (H-CDR3) comprising the amino acid sequence ARSRFAY (SEQ ID NO: 12);
Light chain CDR1 (L-CDR1) comprising the amino acid sequence KASQNVGTNVA (SEQ ID NO: 13);
Light chain CDR2 (L-CDR2) comprising the amino acid sequence SASYRYS (SEQ ID NO:14); and
Light chain CDR3 (L-CDR3) comprising the amino acid sequence QQYNSYPLT (SEQ ID NO:15).